Eli Lilly & Co. (LLY) Misses Q3 EPS by 7c
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,255.40 +0.88%
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $0.88, $0.07 worse than the analyst estimate of $0.95. Revenue for the quarter came in at $5.19 billion versus the consensus estimate of $5.29 billion.
Cialis revenue was $588.2 million. Est. at $594.7 million
Alinta revenue was $570.4 million, est at $551.7 million.
Eli Lilly & Co. reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
- Is the global equity rally broadening? UBS weighs in
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
